Helping prisoners notify their partners about HIV exposure
Official title: Prison-Based HIV Partner Notification in Indonesia
Funded at University of Illinois at Chicago · NIH-11086543 · Data updated 2026-11-12
This study is looking at a friendly way to help people in prison in Indonesia let their past partners know about possible HIV exposure, so they can get tested and treated quickly.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project start | February 1, 2025 |
| Project end | January 31, 2030 |
| Funding year | 2025 |
| Award (this year) | $637,749 |
| NIH project number | 1R01MH138246-01A1 |
| Project ID | NIH-11086543 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals currently incarcerated in Indonesia who are diagnosed with HIV and have former partners at risk of exposure.
✕Less likely to help
Patients who are not incarcerated or those who do not have a history of HIV exposure may not benefit from this research.
What this research studies
This research focuses on improving HIV testing and diagnosis among individuals who have been in contact with the virus, particularly in prison settings in Indonesia. It utilizes a method called Assisted Partner Notification (APN), where trained community health workers help inmates inform their former sexual and drug-using partners about potential HIV exposure. The study aims to evaluate the effectiveness of this approach in encouraging timely testing and treatment referrals for those at risk. By addressing the unique challenges faced by incarcerated individuals, the research seeks to enhance public health outcomes in the community.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of individuals tested for HIV and linked to care, ultimately reducing the spread of the virus.
How similar studies have gone: Previous studies have shown that Assisted Partner Notification can be effective in community settings, suggesting potential success in prison environments as well.
Where this research is happening
-
University of Illinois at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Culbert, Gabriel John — University of Illinois at Chicago
- Study coordinator: Culbert, Gabriel John
Related research
Other NIH-funded projects on the same topics.
-
MSC Secretome Eye Drops to Speed Healing of Corneal Wounds
A new eye drop made from stem cell–secreted factors is being tested to help adults with non-healing corneal wounds recover vision faster.
-
UIC Center for Healthy Work
A national program led by UIC aims to improve the health and well-being of workers through collaborative research and practical solutions.
-
Coordinated Oral Health Promotion for Chicago Kids
A long-running study in Chicago is following children and their caregivers to find ways to reduce tooth decay and improve daily life for families.
-
Targeting p38 MAPK to slow ALS-related axonal damage
Aims to block a specific brain-wide signaling pathway (p38 MAPK) to reduce nerve damage in people with various genetic forms of ALS.
-
Precision nanomedicine to calm inflammation and protect bone in gum disease
A new, targeted nanomedicine approach aims to reduce gum inflammation and prevent bone loss in adults with periodontal disease.
-
Role of DPP in Dental Pulp Stem Cells and their Regenerative Potential
A project explores how a natural tooth protein helps dental pulp stem cells repair and regenerate the tooth’s inner tissue.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.